In this valuable study, Roiuk et al employed a combination of ribosome profiling and reporter assays to provide convincing evidence that eIF2A is not involved in translational regulation in cultured ...

The acute coronary syndrome market is experiencing significant growth, driven by the increasing prevalence of both acute myocardial infarction (AMI) and unstable angina, an aging global population ...

Dupixent® is now used to treat over a million patients globally, with continued growth and expansion in multiple indications for diseases in ...

The "Transfection Reagents & Equipment Market by Product, by Method, by Application, by End-User, and By Region" report has ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Ramesh and Rajeev Juneja of Mankind Pharma fought popular perceptions and made large acquisitions, focussed on specialty ...

Adam Townsend, chief operating officer, has decided to pursue a new opportunity as a chief executive officer at a private biotechnology company and will depart Apellis on February 21, 2025. Since ...

This small interfering RNA (siRNA) therapy works by inhibiting SerpinPC1 mRNA ... transformation - The global digital transformation market in oil and gas industry size is estimated to grow by USD ...

Table 3 Top ten announced mergers and acquisitions of 2006 Full size table Among M&A deals announced ... acquisition of RNAi company Sirna (San Francisco) for $1.1 billion, a 100% premium over ...

Tumour size was measured twice weekly using a digital caliper ... PTEN deficiency led to a marked increase of NADPH levels in HCC and HCT116 cells (figure 2D). Treatment with G6PD siRNA minimised the ...

WVE-007 is an investigational GalNAc-conjugated small interfering RNA (siRNA) designed to silence Inhibin βE (INHBE) gene expression, which would induce fat burning (lipolysis) to decrease body ...